What is the Market Cap of
|
The Current Market Cap of GLAND PHARMA is ₹50,535.5 Cr. |
| Current Share Price: ₹3,070.2 |
| Updated EOD on : May 20,2022. |
Change in Market Cap of GLAND PHARMA
| Market Cap Change(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -1.3% |
-6.3% |
1% |
| SENSEX | 2.9% |
-3.8% |
9.6% |
Peer Comparison with Market Cap of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹50,535.5 Cr | -1.3% | -6.3% | 1% | FULL ANALYTICS | |
| ABBOTT INDIA | ₹38,190.1 Cr | 8.7% | 6.6% | 13.1% | FULL ANALYTICS | |
| ALKEM LABORATORIES | ₹35,885.0 Cr | 3.4% | -11.9% | -1.1% | FULL ANALYTICS | |
| AUROBINDO PHARMA | ₹32,686.6 Cr | 1.3% | -16.8% | -48% | FULL ANALYTICS | |
| AJANTA PHARMA | ₹14,805.7 Cr | 3% | -1.7% | -10.6% | FULL ANALYTICS | |
| ALEMBIC PHARMACEUTICALS | ₹14,798.2 Cr | 1.8% | -0.7% | -22.1% | FULL ANALYTICS | |
| ASTRAZENECA PHARMA INDIA | ₹6,406.8 Cr | 2.9% | -6% | -33% | FULL ANALYTICS | |
| AARTI DRUGS | ₹3,889.2 Cr | 0.3% | -13.1% | -45.4% | FULL ANALYTICS | |
| ADVANCED ENZYME TECHNOLOGIES | ₹3,107.7 Cr | 1.7% | -11.7% | -39.8% | FULL ANALYTICS | |
| AMRUTANJAN HEALTH CARE | ₹2,441.3 Cr | 1.1% | -6.1% | 16.9% | FULL ANALYTICS | |
| ALEMBIC | ₹1,797.5 Cr | 2.5% | -13% | -42.5% | FULL ANALYTICS | |
| BAJAJ HEALTHCARE | ₹897.1 Cr | 6.9% | -5.5% | 8.3% | FULL ANALYTICS | |
| ANUH PHARMA | ₹496.6 Cr | 4.2% | -1.3% | -36.1% | FULL ANALYTICS | |
| ALBERT DAVID | ₹307.6 Cr | 1.9% | -9.9% | 21.1% | FULL ANALYTICS | |
| BAFNA PHARMACEUTICALS | ₹298.1 Cr | -0.8% | -3.2% | -8.1% | FULL ANALYTICS | |
| AMBALAL SARABHAI ENTERPRISES | ₹239.9 Cr | 1.3% | -11% | -34.8% | FULL ANALYTICS | |
| BAL PHARMA | ₹160.2 Cr | 1% | -8.3% | 11% | FULL ANALYTICS | |
| ALPA LABORATORIES | ₹147.2 Cr | 4.1% | -12.1% | 18.3% | FULL ANALYTICS | |
| BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION | ₹127.4 Cr | 3.7% | -10.5% | -50.4% | FULL ANALYTICS | |
| BDH INDUSTRIES | ₹71.1 Cr | 0.5% | -13.3% | 21.5% | FULL ANALYTICS | |
| AURO LABORATORIES | ₹59.7 Cr | 1.5% | -11.6% | -9.6% | FULL ANALYTICS | |
GLAND PHARMA related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE MIDSMALLCAP | 3.7% | -8.4% | 12.6% |
| S&P BSE ALLCAP | 3.2% | -5.8% | 10.3% |
| S&P BSE MID CAP | 3.2% | -8% | 8% |
| S&P BSE 500 | 3.2% | -5.6% | 9.7% |
| S&P BSE LARGE MIDCAP | 3.1% | -5.2% | 9.2% |
| S&P BSE 250 LARGEMIDCAP | 3.1% | -5.3% | 9.5% |
| S&P BSE 200 | 3.1% | -5.2% | 9.3% |
| S&P BSE 100 LARGECAP TMC | 3% | -4.9% | 9.1% |
| S&P BSE HEALTHCARE | 2.8% | -6.4% | -4.8% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY PHARMA | 3.5% | -3.4% | -5.7% |
| NIFTY500 MULTICAP 50:25:25 | 3.4% | -6.8% | 11% |
| NIFTY MNC | 3.3% | -2.6% | 8% |
| NIFTY 500 | 3.1% | -5.7% | 9.7% |
| NIFTY 100 | 3.1% | -4.9% | 8.9% |
| NIFTY 200 | 3% | -5.3% | 9.3% |
| NIFTY LARGE MIDCAP 250 | 3% | -6% | 10.5% |
| NIFTY 100 EQUAL WEIGHT | 2.9% | -7% | 6.9% |
| NIFTY NEXT 50 | 2.8% | -9.3% | 6.4% |
| NIFTY 100 ALPHA 30 | 0.2% | -15.1% | 10.3% |
You may also like the below Video Courses
Check out Annual Financials of Industry Peers
Check out Quarterly Results of Industry Peers
Compare Analytics
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
Browse Intrinsic Value of Industry Peers
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].
